Synthesis of novel biologically active isoflavones

癌症和心脏病是不分青红皂白地影响我们社会的两种主要疾病，并极大地消耗了我们的保健资源。 因此，发现和开发能够治疗这些疾病的药物至关重要。鉴于Novogen Ltd在药物开发到人体临床试验方面取得的成功，本研究中提出的新型甾体酮可能会导致发现新的药物先导物或治疗剂。该项目有可能通过提供新的本地生产的治疗方法，为澳大利亚工业带来巨大的商业利益，并为我们的老龄化人口带来社会利益。

Cancer and heart disease are two of the main diseases that affect our society indiscriminately and put enormous drains on our health-care resources. Therefore, discovery and development of drugs that can treat these diseases are of utmost importance. Given the established success of Novogen Ltd in the development of drugs through to human clinical trials, novel isoflavones proposed in this study may lead to the discovery of new drug leads or therapeutic agents. The project has the potential to deliver enormous commercial benefits to Australian industry and social benefits to our ageing population through provision of new, locally produced therapeutics.